Cargando…

QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors

The search for effective treatment against novel coronavirus (COVID-19) remains a global challenge due to controversies on available vaccines. In this study, data of SARS coronavirus 3C-like protease (3CLpro) inhibitors; a key drug target in the coronavirus genome was retrieved from CHEMBL database....

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishola, Ahmed Adebayo, Adedirin, Oluwaseye, Joshi, Tanuja, Chandra, Subhash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111888/ https://www.ncbi.nlm.nih.gov/pubmed/34020129 http://dx.doi.org/10.1016/j.compbiomed.2021.104483

Ejemplares similares

Pharmacoinformatic study of inhibitory potentials of selected flavonoids against papain-like protease and 3-chymotrypsin-like protease of SARS-CoV-2
por: Tijjani, Habibu, et al.
Publicado: (2022)

Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19
por: Joshi, Tanuja, et al.
Publicado: (2020)

Structural Insight Into the Viral 3C-Like Protease Inhibitors: Comparative SAR/QSAR Approaches
por: Adhikari, Nilanjan, et al.
Publicado: (2017)

Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches
por: Bhowmick, Shovonlal, et al.
Publicado: (2022)

Pharmacoinformatics-based identification of transmembrane protease serine-2 inhibitors from Morus Alba as SARS-CoV-2 cell entry inhibitors
por: Shakya, Anshul, et al.
Publicado: (2021)

Computational investigation of drug bank compounds against 3C-like protease (3CL(pro)) of SARS-CoV-2 using deep learning and molecular dynamics simulation
por: Joshi, Tushar, et al.
Publicado: (2021)

High predictive QSAR models for predicting the SARS coronavirus main protease inhibition activity of ketone-based covalent inhibitors
por: Sepehri, Bakhtyar, et al.
Publicado: (2021)

Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors
por: Ramajayam, R., et al.
Publicado: (2010)

SAR and QSAR of COVID-19 Main Protease–Inhibitor Interactions of Recently X-ray Crystalized Complexes
por: Ali, Hussein M., et al.
Publicado: (2022)

Assessment of activity of chalcone compounds as inhibitors of 3-chymotrypsin like protease (3CL(Pro)) of SARS-CoV-2: in silico study
por: Mathpal, Shalini, et al.
Publicado: (2022)

Pharmacoinformatic Investigation of Silymarin as a Potential Inhibitor against Nemopilema nomurai Jellyfish Metalloproteinase Toxin-like Protein
por: Asirvatham, Ravi Deva, et al.
Publicado: (2023)

Pharmacoinformatics approach for investigation of alternative potential hepatitis C virus nonstructural protein 5B inhibitors
por: Mirza, Muhammad Usman, et al.
Publicado: (2015)

QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
por: Song, Fucheng, et al.
Publicado: (2023)

Empowering pharmacoinformatics by linked life science data
por: Goldmann, Daria, et al.
Publicado: (2016)

Two Inhibitors Against the 3C-Like Proteases of Swine Coronavirus and Feline Coronavirus
por: Zhou, Mengxin, et al.
Publicado: (2021)

Pharmacoinformatic Investigation of Medicinal Plants from East Africa
por: Simoben, Conrad V., et al.
Publicado: (2020)

Using Chou’s 5-steps rule to study pharmacophore-based virtual screening of SARS-CoV-2 Mpro inhibitors
por: Pundir, Hemlata, et al.
Publicado: (2020)

Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors
por: He, Jun, et al.
Publicado: (2020)

Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus
por: Mandadapu, Sivakoteswara Rao, et al.
Publicado: (2013)

Identification of CDK7 Inhibitors from Natural Sources Using Pharmacoinformatics and Molecular Dynamics Simulations
por: Kumar, Vikas, et al.
Publicado: (2021)

Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus
por: Hartini, Yustina, et al.
Publicado: (2021)

Synergistic Inhibitor Binding to the Papain‐Like Protease of Human SARS Coronavirus: Mechanistic and Inhibitor Design Implications
por: Lee, Hyun, et al.
Publicado: (2013)

Identification of Berbamine, Oxyacanthine and Rutin from Berberis asiatica as anti-SARS-CoV-2 compounds: An in silico study
por: Joshi, Tanuja, et al.
Publicado: (2021)

Identification of Novel Ribonucleotide Reductase Inhibitors for Therapeutic Application in Bile Tract Cancer: An Advanced Pharmacoinformatics Study
por: Islam, Md Ataul, et al.
Publicado: (2022)

Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches
por: Kumar, Vikas, et al.
Publicado: (2023)

Ligand-based pharmacophore modeling and QSAR approach to identify potential dengue protease inhibitors
por: Poola, Anushka A., et al.
Publicado: (2023)

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum
por: Kumari, Madhulata, et al.
Publicado: (2016)

Proteases of SARS Coronaviruses
por: Mukherjee, Rukmini, et al.
Publicado: (2023)

Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases
por: Kumari, Madhulata, et al.
Publicado: (2021)

Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 M(pro) Protease
por: Tejera, Eduardo, et al.
Publicado: (2020)

Investigation of Flavonoid Scaffolds as DAX1 Inhibitors against Ewing Sarcoma through Pharmacoinformatic and Dynamic Simulation Studies
por: Yasir, Muhammad, et al.
Publicado: (2023)

Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition
por: Savale, Rutuja Umesh, et al.
Publicado: (2021)

A combined 3D-QSAR and docking studies for the In-silico prediction of HIV-protease inhibitors
por: Ul-Haq, Zaheer, et al.
Publicado: (2013)

Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris
por: Nguyen, Thi Thanh Hanh, et al.
Publicado: (2012)

QSAR based model for discriminating EGFR inhibitors and non-inhibitors using Random forest
por: Singh, Harinder, et al.
Publicado: (2015)

Unveiling of Pyrimidindinones as Potential Anti-Norovirus Agents—A Pharmacoinformatic-Based Approach
por: Ebenezer, Oluwakemi, et al.
Publicado: (2022)

New Drug Design Avenues Targeting Alzheimer’s Disease by Pharmacoinformatics-Aided Tools
por: Arrué, Lily, et al.
Publicado: (2022)

Pharmacoinformatics-Based Approach for Uncovering the Quorum-Quenching Activity of Phytocompounds against the Oral Pathogen, Streptococcus mutans
por: Marimuthu, Shakti Chandra Vadhana, et al.
Publicado: (2023)

Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease
por: Li, Qingxin, et al.
Publicado: (2020)

Pharmacoinformatics and Breed-Based De Novo Hybridization Studies to Develop New Neuraminidase Inhibitors as Potential Anti-Influenza Agents
por: Lotfi, Bourougaa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tkiiociro3fu24o7cf5ljo3ohq